| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/05/2011 | CN101934076A Bivalent marking live attenuated vaccine of non-propagation genetic engineering for resisting classical swine fever and Japanese encephalitis and application |
| 01/05/2011 | CN101934075A Male contraceptive with mumps as vaccine |
| 01/05/2011 | CN101934074A Porcine circovirus II vaccine and production method thereof |
| 01/05/2011 | CN101934073A Bovine viral diarrhea virus (BVDV) transgenosis Astragalus mongholicus vaccine and production method |
| 01/05/2011 | CN101934072A Method for preparing actinobacillus pleuropneumoniae (App) bacterial ghost and method for preparing subunit vaccine by loading pasteurella antigen with App bacterial ghost |
| 01/05/2011 | CN101933909A Vaccine adjuvant effervescent tablet and preparation method thereof |
| 01/05/2011 | CN101933903A 油乳剂疫苗及其制备方法 Oil emulsion vaccine and its preparation method |
| 01/05/2011 | CN101933896A Preparation used for preventing and treating animal viral diseases |
| 01/05/2011 | CN101575587B Abortus Brucella vaccine recombinant strain and application thereof in preparing vaccine |
| 01/05/2011 | CN101508999B Recombinant toxoplasma protein and uses thereof |
| 01/04/2011 | US7865626 Raid storage subsystem using read connection information command to request WWN information for server table and adapter connection table |
| 01/04/2011 | US7863434 Nucleotide sequences coding granulocytic ehrlichia proteins for use in diagnosis, assessment, prognosis and treatment of mammals afflicted with ehrlichiosis |
| 01/04/2011 | US7863426 Antibody purification |
| 01/04/2011 | US7863418 T cell immune response cDNA 7 (TIRC7) protein for use in treatment of organ transplantation rejection, tumor, autoimmune and/or allergic disorders |
| 01/04/2011 | US7863247 Prevention of fetal alcohol syndrome and neuronal cell death with ADNF polypeptides |
| 01/04/2011 | US7863244 Peptides |
| 01/04/2011 | US7863240 Administering a reagent that increases the activity of leptin in a patient with hepatocellular carcinoma, caused by immune suppression, wherein a shift takes place in the Th1/Th2 balance towards a pro-inflammatory state |
| 01/04/2011 | US7863041 Rabies virus vector systems and compositions and methods thereof |
| 01/04/2011 | US7863004 Neoepitope detection of disease using protein arrays |
| 01/04/2011 | US7862994 Preventing fusion of virus and preferential cells; incubate cells with genetically engineered viral particles and viricide, detect reduction in emission energy, reduction in emission indicates prevention of viral fusion and infection |
| 01/04/2011 | US7862829 Enhance immunology response ti immunogen; alpha virus adjuvant or Venezuelan Equine Encephalatis virua adjuvants |
| 01/04/2011 | US7862828 Allergy vaccines containing hybrid polypeptides |
| 01/04/2011 | US7862827 Combination neisserial compositions |
| 01/04/2011 | US7862826 treating an injury to a nervous system of an animal by applying to the injury an effective amount of an antimicrobial peptide, BDNF, IGF-1, and Substance P, wherein the antimicrobial peptide is BNP-1 and wherein the injury comprises an acute spinal cord injury |
| 01/04/2011 | US7862825 Method of controlling tight blood glucose by somatostatin receptor antagonists |
| 01/04/2011 | US7862823 Multivalent vaccine composition with mixed carrier |
| 01/04/2011 | US7862821 Recombinant vaccine against bluetongue virus |
| 01/04/2011 | US7862820 Immunoglobulin chimeric monomer-dimer hybrids |
| 01/04/2011 | US7862819 Mammal polynucleotides; binding to monoclonal antibodies |
| 01/04/2011 | US7862818 Using chemokine specific immunoglobulin to prevent and treat inflammatory bowel disease, colitis and/or sarcoidosis |
| 01/04/2011 | US7862817 Kit to treat ErbB2-expressing cancer in patient; humanized version of monoclonal antibody 2C4; immunoconjugate of humanized antibody conjugated with a cytotoxic agent; patient produces a greater than normal level of ErbB ligand epidermal growth factor, transforming growth factor alpha |
| 01/04/2011 | US7862816 Identifying ephrin inhibitors for use in treatment and prevention of cell proliferative and angiogenesis disorders; antitumor agents |
| 01/04/2011 | US7862815 Methods for inhibiting angiogenesis with inhibitors of proadrenomedullin N-terminal 20 peptide (PAMP) |
| 01/04/2011 | US7862814 Method of inhibiting the proliferation of B cell cancers using TACI-immunoglobulin fusion proteins |
| 01/04/2011 | US7862812 Using sphingosine-1-phosphate (S1P) and/or lysophosphatidic acid (LPA) specific monoclonal antibodies as therapeutic treatment for autoimmune disorders |
| 01/04/2011 | US7862809 Lactobacilic broth prevention or treatment of angiogenic disorders |
| 01/04/2011 | US7862799 Sustained release of antibodies in milk; insertion of antigen releasing device in mammary glands lymph nodes |
| 01/04/2011 | CA2516661C M. haemolytica outer membrane protein plpe as a vaccine or vaccine component against shipping fever |
| 01/04/2011 | CA2487060C Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency |
| 01/04/2011 | CA2486119C Method of isolating an endothelial cell and method of donor specific crossmatching |
| 01/04/2011 | CA2483590C Use of inhibitors of egfr-mediated signal transduction for the treatment of benign prostatic hyperplasia (bph)/prostatic hypertrophy |
| 01/04/2011 | CA2447335C Targeted delivery of drugs for the treatment of viral infections |
| 01/04/2011 | CA2389206C Activation of hcv-specific t cells |
| 01/04/2011 | CA2388301C Modified gp100 and uses thereof |
| 01/04/2011 | CA2382848C Diagnostics and therapeutics for osteoporosis |
| 01/04/2011 | CA2361181C Her-2 binding antagonists |
| 01/04/2011 | CA2360692C Noninvasive vaccination through the skin |
| 01/04/2011 | CA2350127C Avipox vector coding an hiv antigen and a cytokine |
| 01/04/2011 | CA2341239C A preventive or therapeutic agent for pancreatitis comprising il-6 antagonist as an active ingredient |
| 01/04/2011 | CA2340174C Compositions of cpg and saponin adjuvants and methods thereof |
| 01/04/2011 | CA2324165C Recombinant major allergen of the pollen of artemisia vulgaris (mugwort) |
| 01/04/2011 | CA2319672C Compounds and compositions for delivering active agents |
| 01/04/2011 | CA2307000C Veterinary vaccines |
| 01/04/2011 | CA2301920C Vaccine |
| 01/04/2011 | CA2285018C Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof |
| 01/04/2011 | CA2283754C Use of avian antibodies |
| 01/04/2011 | CA2272046C Infectious clones of rna viruses and vaccines and diagnostic assays derived thereof |
| 01/04/2011 | CA2268865C Anti-p53 single-chain antibody fragments and their uses |
| 01/04/2011 | CA2246744C Immunomodulatory complex and use thereof in diseases caused by helicobacter |
| 01/04/2011 | CA2239208C Treatment and diagnosis of infections due to helicobacter pylori |
| 01/04/2011 | CA2163439C Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 01/04/2011 | CA2142575C Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma |
| 01/04/2011 | CA2129899C Dual carrier immunogenic construct |
| 01/04/2011 | CA2068654C Varicella-zoster virus antigen |
| 12/30/2010 | US20100332417 Methods for the detection and quantitation of the p95 component of her2/neu (erbb2) |
| 12/30/2010 | US20100331537 Novel surface antigen |
| 12/30/2010 | US20100331536 CA125 gene and its use for diagnostic and therapeutic interventions |
| 12/30/2010 | US20100331279 Inhibition of Antigen Presentation with Poorly Catabolized Polymers |
| 12/30/2010 | US20100330587 Annexin Proteins and Autoantibodies As Serum Markers For Cancer |
| 12/30/2010 | US20100330560 Immunogenic polypeptide isolated from mycobacterium avium subspecies paratuberculosis and uses thereof |
| 12/30/2010 | US20100330554 Diagnostic kit for solid cancer and medicament for solid cancer therapy |
| 12/30/2010 | US20100330190 Immunogenic compositions and methods of use thereof |
| 12/30/2010 | US20100330184 Injection vehicle for polymer-based formulations |
| 12/30/2010 | US20100330183 Solid dispersing vaccine composition for oral delivery |
| 12/30/2010 | US20100330173 Compounds and methods for treating influenza |
| 12/30/2010 | US20100330167 Nanoparticles for protein drug delivery |
| 12/30/2010 | US20100330162 Spray freeze dry of compositions for pulmonary adminstration |
| 12/30/2010 | US20100330161 Oral delivery of tetanus toxoid |
| 12/30/2010 | US20100330155 METHODS AND COMPOSITIONS FOR IMPROVED THERAPEUTIC EFFECTS WITH siRNA |
| 12/30/2010 | US20100330127 Soluble aggregate, immune tolerance inducer and manufacturing method thereof |
| 12/30/2010 | US20100330126 Attenuated malaria blood-stage vaccine |
| 12/30/2010 | US20100330125 Novel polysaccharide immunogens from clostridium difficile |
| 12/30/2010 | US20100330124 Vaccine compositions and methods of use to protect against infectious disease |
| 12/30/2010 | US20100330123 Albumin-free botulinum toxin formulations |
| 12/30/2010 | US20100330122 VARICELLA ZOSTER VIRUS VIRUS-LIKE PARTICLES (VLPs) AND ANTIGENS |
| 12/30/2010 | US20100330121 Recombinant alphavirus-based vectors with reduced inhibition of cellular macro-molecular synthesis |
| 12/30/2010 | US20100330120 Human parainfluenza viruses having separated p and c genes |
| 12/30/2010 | US20100330119 Chromatography medium, preparation method of the same, and method for producing virus vaccine using the chromatography medium |
| 12/30/2010 | US20100330118 Influenza hemagglutinin and neuraminidase variants |
| 12/30/2010 | US20100330117 Process for treatment of amyotrophic lateral sclerosis, rheumatoid arthritis, tremors/parkinson's disease, multiple sclerosis, non-viral based cancers, alzheimers's disease, muscular dystrophy, attention deficit disorder, attention deficit hyperactivity disorder, complex regional pain syndrome, diabetes, neuropathic pain, spider arthritis, west nile virus, fibromyalgia, shingles, gout, migraine headaches, senile dementia, post polio syndrome, central virus deafness, asthma, chronic pain of unknown origin and hepatitis c |
| 12/30/2010 | US20100330116 Live attenuated salmonella for use as vaccine |
| 12/30/2010 | US20100330115 Multivariable Antigens Complexed with Targeting Humanized Monoclonal Antibody |
| 12/30/2010 | US20100330114 Use of SIRT1 Activators or Inhibitors to Modulate an Immune Response |
| 12/30/2010 | US20100330113 Vaccine Antigens |
| 12/30/2010 | US20100330112 Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response |
| 12/30/2010 | US20100330111 Increase of immune response and targeting by antigens and/or drug linkage |
| 12/30/2010 | US20100330110 Therapeutic and diagnostic uses of antibody specificity profiles |
| 12/30/2010 | US20100330109 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 12/30/2010 | US20100330108 Pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugate |
| 12/30/2010 | US20100330107 Antibody drug conjugates (adc) that bind to 24p4c12 proteins |